Why the study?
Evidence suggests a connection between the systemic inflammatory response index and heart failure prognosis, but its role in idiopathic pulmonary arterial hypertension is not well understood.
Does a higher systemic inflammatory response index (SIRI) predict clinical deterioration in patients with idiopathic pulmonary arterial hypertension?
Population
426 consecutive IPAH patients who underwent right heart catheterization at Fuwai Hospital
Comparison
SIRI > 0.741 vs SIRI ≤ 0.741
Design
Observational cohort study
Authors
Loading...
SIRI may aid IPAH risk stratification; leaves open incremental prognostic value beyond standard markers in prospective validation.
Does a higher systemic inflammatory response index (SIRI) predict clinical deterioration in patients with idiopathic pulmonary arterial hypertension?
SIRI is an independent predictor of clinical deterioration in patients with idiopathic pulmonary arterial hypertension, offering additional prognostic value beyond standard risk scores.
Gao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: